Buprenorphine, Clonidine, and Dexamethasone on Duration of Brachial Plexus Blocks for Upper Extremity Surgery
Recruiting now · Phase 4
Conditions studied: Pain, Postoperative
In brief
The goal of this clinical trial is to learn if there is a difference in morphine requirements in patients after upper extremity surgeries including shoulder arthroscopy. The main question it aims to answer is whether there is a difference between Interscalene brachial plexus blocks with the addition of buprenorphine, dexamethasone, and clonidine and the same block without the adjuvant.
Key facts
- Study ID
- NCT05824832
- Run by
- Loyola University
- People needed
- 120
- Starts
- 2023-02-28
- Expected to finish
- 2026-06-30
- Last updated by the study team
- 2025-03-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients ≥ 18 years old
- Patients undergoing shoulder arthroscopy
- Patients willing to participate and sign informed consent
You may not qualify if…
- Severe COPD/other contraindication to general anesthesia
- Patient with a weight of less than 60 kg
- Dementia, not alert or oriented to person, place, or time
- Chronic pain patient with daily opioid use at home.
- Patient with allergy to local anesthetics
- Patient refusal
- Total shoulder arthroplasty
- Concomitant pain in different area from operative site.
- Pregnancy
- Patient with active infection on the injection sites for the blocks
- Patients unable or willing to understand or comply with the study protocol
Where it is running
- Loyola University Chicago — Maywood, Illinois, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.